International Journal of Pharmaceutics · 2022 · 25 citations · 23 references
PharmacyOncologyPharmacologyCancer PharmacologyDrug DeliveryNanoparticle Drug DeliveryAntibody ConjugationAntibody-drug ConjugatesCancer ImmunotherapyCancer NanomedicineNanomedicineNanoparticle FormulationsActive Tumor TargetingCancer NanotherapyNanoparticle ConjugationNanoparticle-based ChemotherapyNanoparticlesTriple-negative Breast Cancer ImmunotherapyTriple-negative Breast Cancer TherapyTumor-targeted Drug Delivery
23
Sherene Loi, Sathana Dushyanthen, Paul A. Beavis et al. · Clinical Cancer Research · 2015 · 552 citations · Full text
Medicine, Immunology, Oncology +17
Tumor immune evasion arises through loss of TNF sensitivity
Conor J. Kearney, Stephin J. Vervoort, Simon J. Hogg et al. · Science Immunology · 2018 · 393 citations
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
Gaofeng Xiong, Rachel L. Stewart, Jie Chen et al. · Nature Communications · 2018 · 275 citations · Full text
Medicine, Cancer Biology, Oncology +17